• Explore /
  • Poster
  • / Chemotherapy induced profound neutropenia (PN) in patients (pt) with breast cancer (BC) after chemotherapy and plinabulin (Plin) plus pegfilgrastim (Peg) combination versus (vs) peg alone: Final phase 3 results from protective-2 (BPI-2358-106).

Chemotherapy induced profound neutropenia (PN) in patients (pt) with breast cancer (BC) after chemotherapy and plinabulin (Plin) plus pegfilgrastim (Peg) combination versus (vs) peg alone: Final phase 3 results from protective-2 (BPI-2358-106).

Abstract Poster

Authors

null

Yuankai Shi

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China

Yuankai Shi , Douglas W. Blayney , Hryhorii Adamchuk , Qingyuan Zhang , Lihua Du , Lan Huang , Ramon Mohanlal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT03531099

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 546)

DOI

10.1200/JCO.2021.39.15_suppl.546

Abstract #

546

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Douglas W. Blayney

First Author: Douglas W. Blayney

First Author: Jaime Shaw

First Author: Lee S. Schwartzberg